Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Bicycle Therapeutics (NASDAQ:BCYC) through any online brokerage.
Other companies in Bicycle Therapeutics’s space includes: Bright Minds Biosciences (NASDAQ:DRUG), Monopar Therapeutics (NASDAQ:MNPR), Immuneering (NASDAQ:IMRX), Altimmune (NASDAQ:ALT) and ADC Therapeutics (NYSE:ADCT).
Bicycle Therapeutics has a consensus price target of $25.73.
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $6.89 last updated November 13, 2025 at 4:13 PM EST.
There are no upcoming dividends for Bicycle Therapeutics.
Bicycle Therapeutics’s Q3 earnings are confirmed for Thursday, October 30, 2025.
There is no upcoming split for Bicycle Therapeutics.
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.